Orthobond

Orthobond is a biotechnology company that is focused on improving the performance and safety of implantable medical devices.

Orthobond Corp. develops surface modification technology that can be applied to synthetic materials to produce biological responses. It offers a technology based on self-assembled monolayers of phosphonate (SAMP); and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company also provides bioresistant technology to address the need of tissue integration into permanent implants; and AI-SAMP anti-infective technology that helps in preventing a range of orthopedic infections by killing bacteria as they contact the pin surface and preventing biofilm formation, pre and post-operatively. Orthobond Corp. was founded in 2003 and is based in North Brunswick, New Jersey.